2019 Q2 Form 10-Q Financial Statement

#000154908419000006 Filed on August 01, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2018 Q2
Revenue $3.262M $2.967M
YoY Change 9.94% 58.92%
Cost Of Revenue $1.702M $2.000M
YoY Change -14.9% 35.96%
Gross Profit $1.560M $967.0K
YoY Change 61.32% 144.19%
Gross Profit Margin 47.82% 32.59%
Selling, General & Admin $5.159M $6.760M
YoY Change -23.68% 17.67%
% of Gross Profit 330.71% 699.07%
Research & Development $1.499M $1.389M
YoY Change 7.92% -47.23%
% of Gross Profit 96.09% 143.64%
Depreciation & Amortization $240.0K $460.0K
YoY Change -47.83% 15.0%
% of Gross Profit 15.38% 47.57%
Operating Expenses $6.658M $8.152M
YoY Change -18.33% -7.94%
Operating Profit -$5.098M -$7.185M
YoY Change -29.05% -15.06%
Interest Expense $107.0K $160.0K
YoY Change -33.13% -19.19%
% of Operating Profit
Other Income/Expense, Net $2.032M -$793.0K
YoY Change -356.24% -126.86%
Pretax Income -$3.070M -$7.980M
YoY Change -61.53% 44.83%
Income Tax
% Of Pretax Income
Net Earnings -$3.066M -$7.978M
YoY Change -61.57% 44.87%
Net Earnings / Revenue -93.99% -268.89%
Basic Earnings Per Share
Diluted Earnings Per Share -$651.8K -$1.975M
COMMON SHARES
Basic Shares Outstanding 67.67M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q2 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.26M $13.89M
YoY Change -4.54% 29.81%
Cash & Equivalents $13.26M $13.89M
Short-Term Investments
Other Short-Term Assets $610.0K $580.0K
YoY Change 5.17% -3.33%
Inventory $3.724M $2.382M
Prepaid Expenses
Receivables $4.541M $3.547M
Other Receivables $0.00 $0.00
Total Short-Term Assets $22.13M $20.40M
YoY Change 8.48% 33.34%
LONG-TERM ASSETS
Property, Plant & Equipment $1.816M $2.271M
YoY Change -20.04% -11.36%
Goodwill $189.0K $189.0K
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $168.0K $120.0K
YoY Change 40.0% 1.69%
Total Long-Term Assets $3.450M $2.805M
YoY Change 22.99% -22.75%
TOTAL ASSETS
Total Short-Term Assets $22.13M $20.40M
Total Long-Term Assets $3.450M $2.805M
Total Assets $25.58M $23.21M
YoY Change 10.23% 22.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.480M $2.590M
YoY Change -4.25% 25.24%
Accrued Expenses $2.768M $3.162M
YoY Change -12.46% 28.64%
Deferred Revenue $1.369M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $2.333M $2.333M
YoY Change 0.0% 140.02%
Total Short-Term Liabilities $9.343M $9.395M
YoY Change -0.55% 42.63%
LONG-TERM LIABILITIES
Long-Term Debt $1.535M $3.746M
YoY Change -59.02% -36.57%
Other Long-Term Liabilities $45.00K $36.00K
YoY Change 25.0% -50.68%
Total Long-Term Liabilities $1.580M $3.782M
YoY Change -58.22% -36.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.343M $9.395M
Total Long-Term Liabilities $1.580M $3.782M
Total Liabilities $20.18M $15.58M
YoY Change 29.5% -9.95%
SHAREHOLDERS EQUITY
Retained Earnings -$180.8M -$160.0M
YoY Change 12.95% 24.21%
Common Stock $75.00K $61.00K
YoY Change 22.95% 134.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.404M $7.626M
YoY Change
Total Liabilities & Shareholders Equity $25.58M $23.21M
YoY Change 10.23% 22.59%

Cashflow Statement

Concept 2019 Q2 2018 Q2
OPERATING ACTIVITIES
Net Income -$3.066M -$7.978M
YoY Change -61.57% 44.87%
Depreciation, Depletion And Amortization $240.0K $460.0K
YoY Change -47.83% 15.0%
Cash From Operating Activities -$4.530M -$6.050M
YoY Change -25.12% -37.04%
INVESTING ACTIVITIES
Capital Expenditures -$50.00K $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$50.00K $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.600M -590.0K
YoY Change -1557.63% -105.4%
NET CHANGE
Cash From Operating Activities -4.530M -6.050M
Cash From Investing Activities -50.00K 0.000
Cash From Financing Activities 8.600M -590.0K
Net Change In Cash 4.020M -6.640M
YoY Change -160.54% -653.33%
FREE CASH FLOW
Cash From Operating Activities -$4.530M -$6.050M
Capital Expenditures -$50.00K $0.00
Free Cash Flow -$4.480M -$6.050M
YoY Change -25.95% -36.32%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001549084
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
74918393 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
EKSO BIONICS HOLDINGS, INC.
dei Entity Shell Company
EntityShellCompany
false
dei Entity Small Business
EntitySmallBusiness
true
CY2018Q4 ekso Accrued Clinical Cost Current
AccruedClinicalCostCurrent
227000 USD
ekso Common Stock Contribution
CommonStockContribution
103000 USD
ekso Other Income Expense
OtherIncomeExpense
-277000 USD
CY2018Q2 ekso Change In Fair Value Contingent Liabilities
ChangeInFairValueContingentLiabilities
-3000 USD
ekso Change In Fair Value Contingent Liabilities
ChangeInFairValueContingentLiabilities
15000 USD
CY2019Q2 ekso Accrued Clinical Cost Current
AccruedClinicalCostCurrent
307000 USD
CY2019Q2 ekso Change In Fair Value Contingent Liabilities
ChangeInFairValueContingentLiabilities
0 USD
ekso Change In Fair Value Contingent Liabilities
ChangeInFairValueContingentLiabilities
-1000 USD
ekso Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
-1504000 shares
ekso Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
6667000 shares
ekso Common Stock Contribution
CommonStockContribution
118000 USD
CY2019Q2 ekso Contingent Success Fee Liability
ContingentSuccessFeeLiability
35000 USD
ekso Contract With Customer Liability Deferral Of Revenue
ContractWithCustomerLiabilityDeferralOfRevenue
1346000 USD
CY2019Q2 ekso Debt Covenant Covenant Compliance Unrestricted Cash
DebtCovenantCovenantComplianceUnrestrictedCash
4546000 USD
CY2018Q4 ekso Deferred Device Revenue
DeferredDeviceRevenue
70000 USD
CY2019Q2 ekso Deferred Device Revenue
DeferredDeviceRevenue
34000 USD
CY2018Q4 ekso Deferred Extended Maintenance And Support
DeferredExtendedMaintenanceAndSupport
2114000 USD
CY2019Q2 ekso Deferred Extended Maintenance And Support
DeferredExtendedMaintenanceAndSupport
2705000 USD
CY2018Q4 ekso Deferred Royalties
DeferredRoyalties
300000 USD
CY2019Q2 ekso Deferred Royalties
DeferredRoyalties
300000 USD
ekso Gain Loss On Change In Fair Value Contingent Liabilities
GainLossOnChangeInFairValueContingentLiabilities
17000 USD
ekso Gain Loss On Change In Fair Value Contingent Liabilities
GainLossOnChangeInFairValueContingentLiabilities
-1000 USD
CY2018Q2 ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
-213000 USD
ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
520000 USD
CY2019Q2 ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
2737000 USD
ekso Gain Loss On Warrant Liability
GainLossOnWarrantLiability
1615000 USD
CY2018Q2 ekso Gain Loss On Warrant Modification
GainLossOnWarrantModification
0 USD
ekso Gain Loss On Warrant Modification
GainLossOnWarrantModification
0 USD
CY2019Q2 ekso Gain Loss On Warrant Modification
GainLossOnWarrantModification
0 USD
ekso Gain Loss On Warrant Modification
GainLossOnWarrantModification
-257000 USD
ekso Operating Leases Liability Initial Recognition
OperatingLeasesLiabilityInitialRecognition
1498000 USD
ekso Operating Leases Rent Expense Annual Incremental Percentage Increase
OperatingLeasesRentExpenseAnnualIncrementalPercentageIncrease
0.03
ekso Operating Leases Right Of Use Asset Initial Recognition
OperatingLeasesRightOfUseAssetInitialRecognition
1454000 USD
CY2018Q2 ekso Other Income Expense
OtherIncomeExpense
-420000 USD
CY2019Q2 ekso Other Income Expense
OtherIncomeExpense
108000 USD
ekso Other Income Expense
OtherIncomeExpense
-31000 USD
CY2019Q2 ekso Proceeds From Issuance Of Common Stock Preference Stock And Warrants
ProceedsFromIssuanceOfCommonStockPreferenceStockAndWarrants
2313000 USD
ekso Proceeds From Issuance Of Common Stock Preference Stock And Warrants
ProceedsFromIssuanceOfCommonStockPreferenceStockAndWarrants
2313000 USD
ekso Sales Earnout
SalesEarnout
28000 USD
ekso Sales Earnout
SalesEarnout
22000 USD
ekso Shares Issued Capital Contribution
SharesIssuedCapitalContribution
508000 USD
ekso Shares Issued Capital Contribution
SharesIssuedCapitalContribution
191000 USD
CY2018Q1 ekso Stock Issued During Period Value Equiposis Supply And Sales Earnouts
StockIssuedDuringPeriodValueEquiposisSupplyAndSalesEarnouts
28000 USD
CY2019Q1 ekso Stock Issued During Period Value Equiposis Supply And Sales Earnouts
StockIssuedDuringPeriodValueEquiposisSupplyAndSalesEarnouts
22000 USD
CY2016Q4 ekso Success Fee Expenses
SuccessFeeExpenses
250000 USD
ekso Transfer Of Property And Equipment From Inventory
TransferOfPropertyAndEquipmentFromInventory
684000 USD
ekso Transfer Of Property And Equipment From Inventory
TransferOfPropertyAndEquipmentFromInventory
-117000 USD
ekso Unrestricted Cash
UnrestrictedCash
8716000 USD
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3156000 USD
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2480000 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3660000 USD
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4541000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3541000 USD
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2768000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-92000 USD
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-50000 USD
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
173903000 USD
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
186142000 USD
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
892000 USD
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
402000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
636000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
557000 USD
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
402000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1294000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
557000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1193000 USD
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
128000 USD
CY2019Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
119000 USD
CY2018Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6390000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6390000 shares
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15121000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15121000 shares
CY2018Q4 us-gaap Assets
Assets
17655000 USD
CY2019Q2 us-gaap Assets
Assets
25583000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
14967000 USD
CY2019Q2 us-gaap Assets Current
AssetsCurrent
22133000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27813000 USD
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13890000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7655000 USD
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13262000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-13923000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
5607000 USD
CY2019Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3396000 shares
CY2019Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
8559000 shares
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
141429000 shares
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
141429000 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62963000 shares
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
74895000 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62963000 shares
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
74895000 shares
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
63000 USD
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
75000 USD
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7658000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15764000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3172000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9575000 USD
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2597000 USD
CY2019Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3130000 USD
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1102000 USD
CY2019Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1369000 USD
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1495000 USD
CY2018Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1495000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2019Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1761000 USD
CY2018 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.5
us-gaap Depreciation
Depreciation
888000 USD
us-gaap Depreciation
Depreciation
493000 USD
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
84000 USD
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
55000 USD
CY2019Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1369000 USD
CY2019Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1761000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
813000 USD
CY2019Q2 us-gaap Contractual Obligation
ContractualObligation
803000 USD
CY2019Q2 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
50000 USD
CY2018Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2000000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3750000 USD
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1702000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3719000 USD
CY2018Q4 us-gaap Customer Advances And Deposits
CustomerAdvancesAndDeposits
62000 USD
CY2019Q2 us-gaap Customer Advances And Deposits
CustomerAdvancesAndDeposits
73000 USD
CY2019Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
3940000 USD
CY2019Q2 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.1044
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.1045
CY2019Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-72000 USD
CY2018Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
51000 USD
CY2019Q2 us-gaap Deferred Rent Credit
DeferredRentCredit
18000 USD
CY2018Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1102000 USD
CY2018Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
585000 USD
CY2019Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
6561000 USD
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-94000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
7000 USD
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2446000 USD
CY2019Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1865000 USD
CY2018Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
35000 USD
CY2019Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
36000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-234000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-34000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-54000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2827000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6564000 USD
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2120000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4437000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
189000 USD
CY2019Q2 us-gaap Goodwill
Goodwill
189000 USD
CY2018Q2 us-gaap Gross Profit
GrossProfit
967000 USD
us-gaap Gross Profit
GrossProfit
1736000 USD
CY2019Q1 us-gaap Grants Receivable
GrantsReceivable
1500000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
1560000 USD
us-gaap Gross Profit
GrossProfit
3159000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
8000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
210000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-654000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
678000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
931000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
215000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
102000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
584000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
533000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
198000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
260000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-757000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
182000 USD
CY2018Q2 us-gaap Interest Expense
InterestExpense
160000 USD
us-gaap Interest Expense
InterestExpense
324000 USD
CY2019Q2 us-gaap Interest Expense
InterestExpense
107000 USD
us-gaap Interest Expense
InterestExpense
228000 USD
us-gaap Interest Paid Net
InterestPaidNet
238000 USD
us-gaap Interest Paid Net
InterestPaidNet
183000 USD
CY2018Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
730000 USD
CY2019Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
673000 USD
CY2018Q4 us-gaap Inventory Gross
InventoryGross
3737000 USD
CY2019Q2 us-gaap Inventory Gross
InventoryGross
3919000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
3371000 USD
CY2019Q2 us-gaap Inventory Net
InventoryNet
3724000 USD
CY2018Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2676000 USD
CY2019Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
2800000 USD
CY2018Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
366000 USD
CY2019Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
195000 USD
CY2018Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
331000 USD
CY2019Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
446000 USD
us-gaap Inventory Write Down
InventoryWriteDown
157000 USD
us-gaap Inventory Write Down
InventoryWriteDown
24000 USD
CY2018Q2 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
CY2019Q2 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
706000 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
706000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
32000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1653000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
0 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
262000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
565000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
553000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
273000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
326000 USD
CY2019Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2019Q2 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P12M
CY2018Q4 us-gaap Liabilities
Liabilities
14927000 USD
CY2019Q2 us-gaap Liabilities
Liabilities
20179000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17655000 USD
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25583000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10132000 USD
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
9343000 USD
CY2019Q2 us-gaap Long Term Debt
LongTermDebt
3868000 USD
CY2019Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
2333000 USD
CY2019Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
440000 USD
CY2019Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
2333000 USD
CY2019Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
1167000 USD
CY2019Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1535000 USD
CY2018Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
2648000 USD
CY2019Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
1535000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-994000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15368000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-60000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12804000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9708000 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-7899000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-7978000 USD
us-gaap Net Income Loss
NetIncomeLoss
-15877000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-6551000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-3066000 USD
us-gaap Net Income Loss
NetIncomeLoss
-9617000 USD
CY2018Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7978000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-15877000 USD
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3066000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9617000 USD
CY2018Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2333000 USD
CY2019Q2 us-gaap Notes Payable Current
NotesPayableCurrent
2333000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
8152000 USD
us-gaap Operating Expenses
OperatingExpenses
17532000 USD
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
6658000 USD
us-gaap Operating Expenses
OperatingExpenses
13169000 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7185000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-15796000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5098000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-10010000 USD
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
642000 USD
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1327000 USD
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 USD
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
393000 USD
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 USD
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
934000 USD
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 USD
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1277000 USD
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.105
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y11M9D
CY2018Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
317000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
460000 USD
CY2019Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
130000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
270000 USD
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
256000 USD
CY2019Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
220000 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
134000 USD
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
168000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-207000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
320000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
148000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-106000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
320000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
113000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-106000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
42000 USD
CY2018Q4 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
270000 USD
CY2019Q2 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
46000 USD
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
67000 USD
CY2019Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
45000 USD
CY2018Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-793000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-81000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2032000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
393000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
31000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
60000 USD
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
281000 USD
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
606000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
16325000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
228000 USD
CY2018Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
307000 USD
CY2019Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
294000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2365000 USD
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1816000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-109000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
50000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
994000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1185000 USD
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1389000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3197000 USD
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1499000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2883000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-171146000 USD
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-180763000 USD
CY2018Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2967000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5486000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3262000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6878000 USD
CY2019Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
633000 USD
CY2019Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
998000 USD
CY2019Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1426000 USD
CY2019Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P6M
CY2019Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2019Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2018Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3933000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7786000 USD
CY2019Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3039000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5848000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1294000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1193000 USD
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.89
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.89
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.02
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.02
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0285
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0209
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0212
CY2016Q4 us-gaap Share Price
SharePrice
8.00
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2018Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
190000 USD
CY2018Q2 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
40000 USD
CY2019Q2 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
919000 USD
us-gaap Stock Issued1
StockIssued1
230000 USD
us-gaap Stock Issued1
StockIssued1
919000 USD
CY2018Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
508000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
191000 USD
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7305000 USD
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2393000 USD
CY2018Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-62000 USD
CY2018Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
55000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
173000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
21391000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
14841000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
7626000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
2728000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
4534000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
5404000 USD
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
60621000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
60386000 shares
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
70702000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
67886000 shares
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk and Other Risks and Uncertainties</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and accounts receivable. The Company maintains its cash accounts in excess of federally insured limits. However, the Company believes it is not exposed to significant credit risk due to the financial position of the depository institutions in which these deposits are held. The Company extends credit to customers, most of which are hospitals or other large nationally recognizable institutions, in the normal course of business. Concentrations of credit risk with respect to accounts receivable exist to the full extent of amounts presented in the condensed consolidated financial statements. The Company does not require collateral from its customers to secure accounts receivable.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable are derived from the sale of products shipped to and services performed for customers. Invoices are aged based on contractual terms with the customer. The Company reviews accounts receivable for collectability and records an allowance for credit losses, as needed. The Company has not experienced any material losses related to accounts receivable as of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Many of the sales contracts with customers outside of the U.S. are settled in a foreign currency. The Company does not enter into any foreign currency hedging agreements and is susceptible to gains and losses from foreign currency fluctuations. To date, the Company has not experienced significant gains or losses upon settling foreign currency denominated accounts receivable.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">June&#160;30, 2019</font><font style="font-family:inherit;font-size:10pt;">, the Company had </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> customers with an accounts receivable balance totaling </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;"> or more of the Company&#8217;s total accounts receivable compared with one customer as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> (</font><font style="font-family:inherit;font-size:10pt;">19%</font><font style="font-family:inherit;font-size:10pt;">).</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the </font><font style="font-family:inherit;font-size:10pt;">three months ended June 30, 2019</font><font style="font-family:inherit;font-size:10pt;">, the Company had one customer with sales of </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;"> or more of the Company&#8217;s total revenue (</font><font style="font-family:inherit;font-size:10pt;">31%</font><font style="font-family:inherit;font-size:10pt;">), compared with </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> customers in the </font><font style="font-family:inherit;font-size:10pt;">three months ended June 30, 2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the </font><font style="font-family:inherit;font-size:10pt;">six months ended June 30, 2019</font><font style="font-family:inherit;font-size:10pt;">, the Company had one customer with sales of </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;"> or more of the Company&#8217;s total revenue (</font><font style="font-family:inherit;font-size:10pt;">21%</font><font style="font-family:inherit;font-size:10pt;">), compared with </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> customers in the </font><font style="font-family:inherit;font-size:10pt;">six months ended June 30, 2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet, and the reported amounts of revenues and expenses during the reporting period. For the Company, these estimates include, but are not limited to, revenue recognition, deferred revenue and the deferral of the associated costs, future warranty costs, accounting for leases, useful lives assigned to long-lived assets, valuation of inventory, realizability of deferred tax assets, the valuation of employee stock options and warrants, and contingencies. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name View Source Status
0001549084-19-000006-index-headers.html Edgar Link pending
0001549084-19-000006-index.html Edgar Link pending
0001549084-19-000006.txt Edgar Link pending
0001549084-19-000006-xbrl.zip Edgar Link pending
ekso-20190630.xml Edgar Link completed
ekso-20190630.xsd Edgar Link pending
ekso-20190630_cal.xml Edgar Link unprocessable
ekso-20190630_def.xml Edgar Link unprocessable
ekso-20190630_lab.xml Edgar Link unprocessable
ekso-20190630_pre.xml Edgar Link unprocessable
ekso-63019x10q.htm Edgar Link pending
ekso-63019xex102.htm Edgar Link pending
ekso-63019xex311.htm Edgar Link pending
ekso-63019xex312.htm Edgar Link pending
ekso-63019xex321.htm Edgar Link pending
ekso-63019xex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending